News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Videos|July 25, 2022

A portable ultrasound device?

Author(s)Morgan Ebert, Managing Editor

John Martin, MD, chief medical officer at Butterfly Network, discusses a recent study published in NEJM Evidence, which investigated Butterfly iQ vs a commercial ultrasound machine to detect gestational age.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Early ultrasound linked to improved fetal anomaly detection | Image Credit: © homonstock - © homonstock - stock.adobe.com.

Early ultrasound linked to improved fetal anomaly detection

ByCeleste Krewson, Assistant Editor

December 11th 2025

First trimester obstetric ultrasound | Image Credit: © Alexander Raths - stock.adobe.com.

First trimester obstetric ultrasound

ByHolly A. Rankin, MD,Melissa C. Matulich, MD, MAS

November 18th 2025

Supplemental molecular breast imaging improves cancer detection in dense breasts | Image Credit: © okrasiuk - stock.adobe.com.

Supplemental molecular breast imaging improves cancer detection in dense breasts

ByMorgan Ebert, Managing Editor

October 10th 2025

Megan Wasson, DO, FACOG

Megan Wasson, DO, on advancing endometriosis care through imaging, surgical precision, and mentorship

ByMegan Wasson, DO, FACOG

May 19th 2025

Wasson and Colak

Megan Wasson, DO, and Ceylan Colak, MD, share how multidisciplinary collaboration advances endometriosis diagnosis and treatment

ByMegan Wasson, DO, FACOG,Ceylan Colak, MD

May 18th 2025

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

DARE to PLAY sildenafil cream becomes commercially available for women in select states

FDA approves gepotidacin (Blujepa) oral therapy for uncomplicated urogenital gonorrhea

Early ultrasound linked to improved fetal anomaly detection

Maternal GBS vaccine (GBS-AlpN) shows immunogenicity and acceptable safety in phase 2 trial

Zoliflodacin demonstrated non-inferiority in adults and adolescents with gonorrhea

© 2025 MJH Life Sciences^®

All rights reserved.